Study of antimicrobial qualities of antiseptic remedies, which contain decamethoxin

Authors

  • O. O. Gonchar National Pirogov Memorial Medical University, Ukraine
  • O. A. Nazarchuk National Pirogov Memorial Medical University, Ukraine
  • D. V. Paliy National Pirogov Memorial Medical University, Ukraine
  • I. V. Kovalenko National Pirogov Memorial Medical University, Ukraine
  • O. V. Yatsula National Pirogov Memorial Medical University, Ukraine

DOI:

https://doi.org/10.24959/ubphj.16.15

Keywords:

antiseptics, decamethoxin, decasan, auridecsan, horosten, septefril

Abstract

In the research the effectiveness of antiseptic remedies, which contain decamethoxin® (DCM). Microbicidal (Pilot Manufacturing of Institute of Organic Chemistry of National Academy of Sciences of Ukraine) and its remedies’ forms (auridexan (AU), horosten® (HS), decasan® (DS), septefril (SF). The study was carried out on clinical strains of S. aureus (n 85), E. coli (n 22), P. aeruginosa (n 16), C. albicans (n 12) and was compared with museum strains, got from the museum of alive microbe cultures of Vinnytsya National Pirogov Memorial Medical University. Antimicrobial qualities of antiseptics were studied by means of serial dilutions method. The results of antimicrobial activity of remedies was analysed by minimal cidal concentration (МСС). We found, that DCM® (MCC – 3,67±2,71 mkg/ml), HS® (3,44±1,60 mkg/ml, DS® (3,06±1,95 mkg/ml), SF (4,32±2,47 mkg/ml) had their microbicidal activity against clinical strains of S. aureus. Such remedies of generic  DCM® asAU, HS®, DS were found to have no difference in antimicrobial activity (р<0,05). Antimicrobial activity of DCM® (MCC – 26,8±17,5 mkg/ml) and its remedies horosten®, septefril on clinical strains of E. coli was significantly alike antimicrobial activity of museum strain of E. coli ATCC 25922 (MCC – 7,8 – 31,25 mkg/ml). clinical strains of P. aeruginosa were resistant to remedies of generic DCM® (MCC – 125-250 mkg/ml). C. albicans were sensitive to remedies of DCM® in cidal concentrations 3,9 – 31,25 mkg/ml. Effective antimicrobial qualities of generic decamethoxin® and its remedies (auridexan, horosten®, decasan®, septefril) are advisable to be used in fighting infection, caused by antibiotocresistant strains of S. aureus, E. coli, C. albicans.

References

Вивчення властивостей, еквівалентності антимікробного препарату декаметоксину / Г. К. Палій, Д. В. Палій, О. О. Гончар [та ін.] // XIII з’їзд Тов. мікробіологів України ім. С. М. Виноградського, 1-6 жовтня 2013 р. – Ялта, 2013. – С. 310.

Визначення чутливості мікроорганізмів до антибактеріальних препаратів: методичні вказівки МВ 9.9.5 – 143 / [Некрасова Л.С., Свита В.М., Глушкевич Т.Г. та ін.]. – К. – 2007. – 74.

Декаметоксин, порошок (субстанція). Державний реєстр лікарських засобів МОЗ України. Реєстраційне посвідчення на лікарський засіб № UA/12128/01/01. Наказ МОЗ України від 13.04.2012 № 264.

Машковский М. Д. Лекарственные средства / Машковский М. Д.– 15-е изд., перераб., испр. и доп.. – М.: РИА «Новая волна»: издатель Умеренков, 2007. – С. 331; 953.

Мікробіологічне клінічне обґрунтування профілактичних, лікувальних властивостей нових антисептиків / Г. К. Палій, Н. В. Задерей, Д. В. Палій та ін. // Українські медичні вісті: Наук.-практ. часопис: XV конгрес СФУЛТ, 16-18 жовтня 2014 р. – Чернівці–Київ–Чикаго, 2014. – Т. 11, № 1-4 (80-83). – С. 282.

Протимікробна дія антисептичних препаратів, антибіотиків на збудники запальних захворювань / В. Г. Палій, В. В. Сухляк, Д. В. Палій [та ін.] // Biomedical and Biosocial Anthropology. – 2014. – № 22. – С. 44-46.

Downloads

Published

2016-02-04

Issue

No. 1(42) (2016)

Section

Microbiological research

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).